ASRM RPL “UPDATE” 2026

Dr. Chapa's episode covers the June 2026 ASRM (American Society for Reproductive Medicine) updated guidance on recurrent pregnancy loss (RPL), the first major update in over a decade. The episode focuses specifically on the new decision tree algorithm introduced in this guidance and emphasizes the pivotal 'first pass' triage test that initiates the diagnostic workup. The episode promises to review this initial screening test and explain its clinical implications for practitioners. The source material references the official ASRM Committee Opinion from 2026 and a 2024 Obstetrics & Gynecology journal article on RPL evaluation, suggesting the episode is grounded in current evidence-based medicine. The 24-minute format suggests a focused, clinical pearl-style discussion rather than an exhaustive deep dive. However, the show notes provide minimal detail about what specific findings or recommendations are actually discussed, what the triage test entails, or what clinical implications are drawn. There is no indication of guest experts, case discussions, or concrete takeaways beyond the promise to review the algorithm and first test. The episode appears designed for an OBGYN or reproductive medicine audience familiar with RPL management rather than general medical education.

Verdict: A timely, focused clinical update on a major guideline with solid sourcing, but minimal show notes make it hard to assess depth, clarity, or whether the promised content is substantive enough to justify the listen for busy clinicians.

Science rubric

• Scientific accuracy n/a

  Show notes cite authoritative sources (ASRM 2026 guidance, peer-reviewed journal) but provide no specific claims to evaluate for accuracy

• Clarity for non-experts n/a

  No content detail provided; episode appears aimed at clinical practitioners, not lay audiences

• Sense of discovery 3/5 25%

  Covers a newly released (June 2026) major guideline update, which is timely and relevant to the field, but framing as 'update' rather than novel discovery

• Substance 2/5 25%

  Show notes promise review of one algorithm and one triage test in 24 minutes; limited scope and no indication of depth, cases, or supporting discussion

• Delivers on its title 4/5 25%

  Title explicitly promises ASRM RPL update review; show notes confirm focus on the 2026 guidance and decision tree, though depth of coverage is unclear

• Value for time 3/5 25%

  24 minutes is reasonable for a clinical pearl on a single triage test, but without content detail, pacing cannot be fully assessed

How we score Science

Worth it if you are an OBGYN or reproductive medicine provider who needs a quick briefing on the 2026 ASRM RPL guidance and its initial diagnostic algorithm.

Based on the episode description. AI-generated; it can be wrong.